Skip to main content
PMC home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1995 Apr;15(4):2191–2196. doi: 10.1128/mcb.15.4.2191

Transcriptional regulation of estrogen receptor in breast carcinomas.

E C deConinck 1, L A McPherson 1, R J Weigel 1
PMCID: PMC230447  PMID: 7891714

Abstract

An important transcriptional regulatory element of the estrogen receptor (ER) gene that binds a protein expressed in ER-positive breast carcinomas has been identified. Using a transient expression assay, we identified a 75-bp region of the 5' untranslated leader of the ER gene which augments expression from the ER promoter. This region contains two binding sites for a protein, estrogen receptor factor 1 (ERF-1), which is expressed in ER-positive breast carcinomas. A concatenated ERF-1 binding site probe identified a 30,000-Da protein. Low-level ERF-1 expression was detected in normal human mammary epithelial cells. Abundant ERF-1 expression was also found in endometrial carcinoma cell lines that express the ER-positive phenotype. These results indicate that ERF-1 expression represents a common mechanism of ER regulation in hormonally responsive carcinomas.

Full Text

The Full Text of this article is available as a PDF (275.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Band V., Sager R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1249–1253. doi: 10.1073/pnas.86.4.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Castles C. G., Fuqua S. A., Klotz D. M., Hill S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 1993 Dec 15;53(24):5934–5939. [PubMed] [Google Scholar]
  3. Clark G. M., Wenger C. R., Beardslee S., Owens M. A., Pounds G., Oldaker T., Vendely P., Pandian M. R., Harrington D., McGuire W. L. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer. 1993 Mar 15;71(6 Suppl):2157–2162. doi: 10.1002/1097-0142(19930315)71:6+<2157::aid-cncr2820711606>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  4. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 1992 Jan 11;20(1):3–26. doi: 10.1093/nar/20.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuqua S. A., Fitzgerald S. D., Allred D. C., Elledge R. M., Nawaz Z., McDonnell D. P., O'Malley B. W., Greene G. L., McGuire W. L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 1992 Jan 15;52(2):483–486. [PubMed] [Google Scholar]
  6. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  7. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
  8. Ince B. A., Zhuang Y., Wrenn C. K., Shapiro D. J., Katzenellenbogen B. S. Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem. 1993 Jul 5;268(19):14026–14032. [PubMed] [Google Scholar]
  9. Keaveney M., Klug J., Dawson M. T., Nestor P. V., Neilan J. G., Forde R. C., Gannon F. Evidence for a previously unidentified upstream exon in the human oestrogen receptor gene. J Mol Endocrinol. 1991 Feb;6(1):111–115. doi: 10.1677/jme.0.0060111. [DOI] [PubMed] [Google Scholar]
  10. Kleinman D., Douvdevani A., Schally A. V., Levy J., Sharoni Y. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):96–102. doi: 10.1016/s0002-9378(94)70391-4. [DOI] [PubMed] [Google Scholar]
  11. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  12. Kuramoto H., Tamura S., Notake Y. Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol. 1972 Dec 15;114(8):1012–1019. doi: 10.1016/0002-9378(72)90861-7. [DOI] [PubMed] [Google Scholar]
  13. McGuire W. L., Chamness G. C., Fuqua S. A. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 1991 Nov;5(11):1571–1577. doi: 10.1210/mend-5-11-1571. [DOI] [PubMed] [Google Scholar]
  14. Ottaviano Y. L., Issa J. P., Parl F. F., Smith H. S., Baylin S. B., Davidson N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994 May 15;54(10):2552–2555. [PubMed] [Google Scholar]
  15. Piva R., Bianchi N., Aguiari G. L., Gambari R., del Senno L. Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event. J Steroid Biochem Mol Biol. 1993 Nov;46(5):531–538. doi: 10.1016/0960-0760(93)90179-z. [DOI] [PubMed] [Google Scholar]
  16. Ricketts D., Turnbull L., Ryall G., Bakhshi R., Rawson N. S., Gazet J. C., Nolan C., Coombes R. C. Estrogen and progesterone receptors in the normal female breast. Cancer Res. 1991 Apr 1;51(7):1817–1822. [PubMed] [Google Scholar]
  17. Scott G. K., Kushner P., Vigne J. L., Benz C. C. Truncated forms of DNA-binding estrogen receptors in human breast cancer. J Clin Invest. 1991 Aug;88(2):700–706. doi: 10.1172/JCI115356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sundareshan P., Hendrix M. J. Growth, morphologic, and invasive characteristics of early and late passages of a human endometrial carcinoma cell line (RL95-2). In Vitro Cell Dev Biol. 1992 Jul-Aug;28A(7-8):544–552. doi: 10.1007/BF02634139. [DOI] [PubMed] [Google Scholar]
  19. Watts C. K., Handel M. L., King R. J., Sutherland R. L. Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):529–536. doi: 10.1016/0960-0760(92)90378-v. [DOI] [PubMed] [Google Scholar]
  20. Way D. L., Grosso D. S., Davis J. R., Surwit E. A., Christian C. D. Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro. 1983 Mar;19(3 Pt 1):147–158. doi: 10.1007/BF02618053. [DOI] [PubMed] [Google Scholar]
  21. Weigel R. J., deConinck E. C. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res. 1993 Aug 1;53(15):3472–3474. [PubMed] [Google Scholar]
  22. White R., Lees J. A., Needham M., Ham J., Parker M. Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol. 1987 Oct;1(10):735–744. doi: 10.1210/mend-1-10-735. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES